Cuban treatment for diabetic foot ulcer and the impact on its health system were the most debated topics during an online conference held between managers and health specialists from Cuba and Turkmenistan.
Dr. Dalsy Torres Ávila, 1st Degree specialist in Intensive-Intensive Internal Medicine, explained in detail to Turkmen colleagues the national health system of the Island that allows providing a high level of care to patients and directing actions to prevent and cure the disease. diabetic foot.
The Caribbean professor explained to the participants that the Cuban drug HEBERPROT-P is a unique compound of its kind in the world for the treatment of this disease and has multiple advantages.
He reported that the treatment with HEBERPROT-P was developed by the Center for Genetic Engineering and Biotechnology (CIGB) and after a long process of research and clinical trials to validate its results, it is already in all the health units of the Cuban nation and from various countries of the world.
The specialists of that Central Asian nation expressed interest in boosting medical cooperation and the exchange of medicines with Cuba.
The video conference was organized by the Cuban Embassy in Azerbaijan and the Ministries of Foreign Affairs and Health of the Republic of Turkmenistan.